Schizoaffective

5 Domains of Negative Symptoms of Schizophrenia

June 07, 2018

Negative symptoms identified from the Negative Symptom Assessment and the behaviors that might be observed in each of 5 domains.

Olfactory Functioning in First-Episode Psychosis

November 27, 2017

What the nose knows in patients with schizophrenia.

When Mom Smokes, Does Schizophrenia Follow?

July 14, 2016

New insights from a large study that relied on objective biomarkers.

Care for First-Episode Psychosis: New Insights From RAISE

January 01, 2016

The first episode of psychosis represents a critical juncture in the treatment of schizophrenia. Here: A synopsis of 2-year outcomes from the NIMH Recovery After an Initial Schizophrenia Episode (RAISE) Early Treatment Program.

Face-Reading Reveals Schizophrenia Risk

October 29, 2015

Deficits in emotion recognition among at-risk patients may predict eventual transition to schizophrenia.

Clinical Findings in Schizophrenia

June 12, 2015

A new network-based neuroimaging study seeks to identify biomarkers across the spectrum of impairment in schizophrenia.

Schizophrenic Disorders: Is There an Elephant?

June 01, 2015

Multiple perspectives are required to fully understand a concept. This seems to be the growing consensus with the schizophrenia spectrum disorders.

Shadows on a Wall: Phenomenology in an Acute Care Setting

February 24, 2015

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.

Modest-But Clinically Useful-Changes for Psychotic Disorders in DSM-5

October 04, 2013

This member of the DSM-5 Work Group for Psychotic Disorders describes the 8 dimensions used to define the presentation of psychosis-the biggest and most clinically important of the changes in the schizophrenia and other psychotic disorders section.